This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Daily volatility influences return paths and allocation choices. This primer covers interpretation and practical tweaks to targets and expectations.
25,212 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A powerful shift is forming: auto plants turning into energy storage hubs to power data centers and grids. This unsto...
When Road releases its Q2 results, the transcript hides clues about growth and risk. This guide translates the road 2...
A hypothetical look at britain's warren buffett pared nearly every position in a $13 billion portfolio during the fir...
Viant DSP is navigating a fast-changing ad-tech landscape in 2026. This analysis breaks down Q1 dynamics, what the nu...
A $250,000 SPIA promises $1,600 a month for life, but it comes with lock-in, fees, and a trade-off between predictabl...
A bold public project turns a mountain of documents into a temporary library in New York. This article breaks down th...
Rumors swirl about a $60.50 per share bid for PayPal by Stripe and Advent, with Block joining the mix. The real prize...
Ford stock keeps going as investors bet on EV momentum and steady cash flow. This guide breaks down the factors fueli...
Ultra-safe funds show shrinking income while principal remains flat, challenging the notion of a truly safe retiremen...
Walmart stock fell today after management signaled a cautious outlook despite solid revenue growth. This article brea...
Whirlpool’s scale appliance demand is a telling gauge of how households spend on big-ticket upgrades. As the housing ...